High efficiency targeting of IFN-α activity: Possible applications in fighting tumours and infections
- 1 April 2015
- journal article
- review article
- Published by Elsevier in Cytokine & Growth Factor Reviews
- Vol. 26 (2) , 179-182
Abstract
No abstract availableKeywords
Funding Information
- Labex MAbImprove
- Institut Carnot CALYM
- IUAP P6/36
- GROUP-ID MRP-UGent
- European Community's Seventh Framework Programme (223608)
- Canceropôle – INCa
- ERC Advanced Grant (340941)
This publication has 34 references indexed in Scilit:
- Liver-Targeting of Interferon-Alpha with Tissue-Specific Domain AntibodiesPLOS ONE, 2013
- Structural and dynamic determinants of type I interferon receptor assembly and their functional interpretationImmunological Reviews, 2012
- Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8α+ dendritic cellsJournal of Experimental Medicine, 2011
- Type I interferon is selectively required by dendritic cells for immune rejection of tumorsJournal of Experimental Medicine, 2011
- Structural Linkage between Ligand Discrimination and Receptor Activation by Type I InterferonsCell, 2011
- Anti–ErbB-2 mAb therapy requires type I and II interferons and synergizes with anti–PD-1 or anti-CD137 mAb therapyProceedings of the National Academy of Sciences, 2011
- The Efficacy of Radiotherapy Relies upon Induction of Type I Interferon–Dependent Innate and Adaptive ImmunityCancer Research, 2011
- Targeted delivery of interferon-alpha via fusion to anti-CD20 results in potent antitumor activity against B-cell lymphomaBlood, 2010
- CD20-targeted tetrameric interferon-α, a novel and potent immunocytokine for the therapy of B-cell lymphomasBlood, 2009
- Variations in the Unstructured C-terminal Tail of Interferons Contribute to Differential Receptor Binding and Biological ActivityJournal of Molecular Biology, 2006